PlainPatent
USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Medtronic Holding Company SARL

USPTO PatentsView assignee record - 68 granted patents across 9 technology areas, active 2018–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).

Explore the portfolio See the ranking
68
Total patents granted
9
CPC technology areas
19.2
Avg claims per patent
+72%
5-year filing velocity

The verdict

Medtronic holds 68 US patents across 9 technology areas, rank #5,093 of 50,000 tracked assignees.

#5,093
of 50,000 US assignees by volume
Top 34%
by Innovation Score (40.9/100)
19.2
avg claims per patent
+72%
filing velocity, last 5 yrs

Portfolio overview

Medtronic Holding Company SARL has been granted 68 US utility patents between 2018 and 2025, placing Medtronic Holding Company SARL at rank #5,093 across all assignees tracked by PlainPatent. This portfolio spans 9 distinct Cooperative Patent Classification (CPC) subclasses, averaging 19.2 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a Foreign Corporation, Medtronic Holding Company SARL is one of the more focused assignees in the PatentsView dataset. By volume, Medtronic sits between Kumu Networks, Inc. (68 patents, rank #5,089) and Nutrition & Biosciences USA 4, Inc. (68 patents, rank #5,097) - the closest US assignees by grant volume. The composite Innovation Score of 40.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 43 grants, compared with 25 in the 2015–2019 window, a +72% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Medtronic Holding Company SARL's 19.2 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 9 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Medtronic Holding Company SARL against peers pursuing similar technology classes.

Who files at Medtronic's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Medtronic holds 68 patents at rank #5,093, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Medtronic

By rank, the assignees closest to #5,093 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Medtronic's primary technology class.

Medtronic's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

41 Top 34% higher than 66% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). This entry sits in this band. 50–60: 5,058 US assignees (10%). Above this entry. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

05101520 20182019202020212022202320242025 2
USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table
Medtronic Holding Company SARL patent grants by year, 2015–2025
Year Patents Granted Share of Period
2018 6 8.8%
2019 19 27.9%
2020 10 14.7%
2021 8 11.8%
2022 9 13.2%
2023 7 10.3%
2024 7 10.3%
2025 2 2.9%

Which technologies does Medtronic Holding Company SARL patent most?

Top 9 of 9 technology areas

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Focused
Claim Depth Standard
Velocity Accelerating

Where it ranks

Overall rank by patents

#5,093

Across all tracked assignees

Innovation Score

40.9 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Medtronic Holding Company SARL hold?
Medtronic Holding Company SARL holds 68 US granted patents filed between 2018 and 2025, spanning 9 technology areas.
What is Medtronic Holding Company SARL's Innovation Score?
Medtronic Holding Company SARL has an Innovation Score of 40.9 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Medtronic Holding Company SARL focus on?
Medtronic Holding Company SARL's top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 64 patents. The company has filed patents in 9 CPC subclasses total.
Is Medtronic Holding Company SARL's patent filing rate increasing or decreasing?
Medtronic Holding Company SARL's recent filing velocity is +72% compared to the prior five-year period. This indicates accelerating innovation.
What does claim depth mean for Medtronic Holding Company SARL's patents?
Medtronic Holding Company SARL's patents average 19.2 claims each. This falls within the standard range, providing solid legal coverage.
How is the Medtronic Holding Company SARL patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Medtronic's 68 grants land it in the top 34% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - Medtronic ranks #5,093 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in A61B - see who else leads that technology area. A61B leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.